Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
26
WORX Quote, Financials, Valuation and Earnings
Last price:
$0.59
Seasonality move
:
-37.13%
Day range:
$0.57 - $0.60
52-week range:
$0.49 - $3.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.29x
P/B ratio:
0.30x
Volume:
55.6K
Avg. volume:
2.4M
1-year change:
-72.69%
Market cap:
$1.4M
Revenue:
$3M
EPS (TTM):
-$3.08
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, SCWorx has -- downside to fair value with a price target of -- per share.
WORX vs. S&P 500
-
Over the past 5 trading days, SCWorx has underperformed the S&P 500 by -10.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SCWorx does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SCWorx revenues have been falling on a year-over-year basis for 15 quarters in a row. In the most recent quarter SCWorx reported revenues of $759.7K.
Earnings Growth
-
SCWorx has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SCWorx reported earnings per share of -$0.27.
Enterprise value:
1.3M
EV / Invested capital:
--
Price / LTM sales:
0.29x
EV / EBIT:
--
EV / Revenue:
0.44x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.21x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$934.3K
Return On Assets:
-50.91%
Net Income Margin (TTM):
-108.87%
Return On Equity:
-80.46%
Return On Invested Capital:
-77.97%
Operating Margin:
-51.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4M | $3.8M | $3M | $910.3K | $675.8K | |
| Gross Profit | $1.4M | $1.3M | $746K | $346.7K | $158.5K | |
| Operating Income | -$2.1M | -$1.5M | -$1.3M | -$44.8K | -$380.3K | |
| EBITDA | -$2M | -$4M | -$1M | -$2.6M | -$152.9K | |
| Diluted EPS | -$2.32 | -$3.80 | -$0.76 | -$2.41 | -$0.09 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.2M | $756.5K | $880.7K | $435.8K | $503.4K | |
| Total Assets | $10.6M | $9.1M | $9.2M | $6.3M | $6.3M | |
| Current Liabilities | $4.6M | $2.3M | $2.3M | $2.3M | $1.8M | |
| Total Liabilities | $4.9M | $2.7M | $2.5M | $2.4M | $1.9M | |
| Total Equity | $5.7M | $6.4M | $6.8M | $3.9M | $4.5M | |
| Total Debt | $294K | $433.6K | $147.7K | $90.4K | $47K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$540K | -$806.2K | -$1.1M | -$104.9K | -$134.4K | |
| Cash From Investing | -- | $165K | -- | $165K | -- | |
| Cash From Financing | $718.4K | $483.1K | $1.1M | -$41.1K | $153.4K | |
| Free Cash Flow | -$540K | -$806.2K | -$1.1M | -$104.9K | -$134.4K | |
WORX
Sector
Market Cap
$1.4M
$34.9M
Price % of 52-Week High
17.83%
44.35%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-72.69%
-38.5%
Beta (5-Year)
3.403
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.60
200-day SMA
Sell
Level
$1.26
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.69
Relative Strength Index (RSI14)
Sell
Level
39.98
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-88.8484
50-day SMA
Sell
Level
$0.84
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.1357)
Buy
CA Score
(Annual)
Level (-0.2779)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.8994)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
Stock Forecast FAQ
In the current month, WORX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The WORX average analyst price target in the past 3 months is --.
-
Where Will SCWorx Stock Be In 1 Year?
According to analysts, the consensus estimate is that SCWorx share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SCWorx?
Analysts are divided on their view about SCWorx share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SCWorx is a Sell and believe this share price will rise from its current level to --.
-
What Is SCWorx's Price Target?
The price target for SCWorx over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is WORX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SCWorx is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of WORX?
You can purchase shares of SCWorx via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SCWorx shares.
-
What Is The SCWorx Share Price Today?
SCWorx was last trading at $0.59 per share. This represents the most recent stock quote for SCWorx. Yesterday, SCWorx closed at $0.59 per share.
-
How To Buy SCWorx Stock Online?
In order to purchase SCWorx stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for May 1
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
